Biotech | January 12, 2022
Sinocompound and InCatT launch new Catalyst Screening Service
This service benefits pharmaceutical and fine chemical companies looking to optimise their reactions
This service benefits pharmaceutical and fine chemical companies looking to optimise their reactions
ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a proprietary brain shuttle, for alpha-synucleinopathies, including Parkinson's disease
The long-term partnership aims to make fermentation-based biotin available for the full range of relevant applications as a sustainable, non-chemical, European-sourced alternative
In addition to its favourable activity profile, IBIO123 is formulated for administration by inhalation providing an efficient, rapid and non-invasive delivery method into the lungs via the respiratory tract
Victor Chang Cardiac Research Institute (VCCRI) researcher recognized for his influential work on cardiovascular disease
Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
Intuitive Telepresence (ITP), facilitates remote learning, and encourages interaction and collaboration between surgeons without the need to travel
CuraTeQ and Orion had entered into a licensing agreement, granting marketing and distribution rights for CuraTeQ’s biosimilar products under development in the Nordic states, Austria, Hungary and Slovenia
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
TATA MD’s OmiSure is the only test approved by the ICMR for RT-PCR detection of the Omicron variant
Subscribe To Our Newsletter & Stay Updated
